Melinda Mushonga
Overview
Explore the profile of Melinda Mushonga including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
26
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mushonga M, Ung Y, Louie A, Cheung P, Poon I, Zhang L, et al.
Adv Radiat Oncol
. 2023 Dec;
8(6):101275.
PMID: 38047222
Purpose: The purpose of this study was to identify factors associated with unanticipated radiation therapy (RT) replanning in stage III non-small cell lung cancer (NSCLC). Methods And Materials: Patients from...
2.
Mushonga M, LaVigne A, Alcorn S
Int J Radiat Oncol Biol Phys
. 2023 Aug;
117(2):479-481.
PMID: 37652610
No abstract available.
3.
Rubagumya F, Mushonga M, Abdihamid O, Nyagabona S, Hopman W, Nwamaka L, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jul;
116(5):984-991.
PMID: 37453798
No abstract available.
4.
Mushonga M, Helou J, Weiss J, Dawson L, Wong R, Hosni A, et al.
Cancers (Basel)
. 2023 Jun;
15(10).
PMID: 37345175
Purpose: To retrospectively review the clinical outcomes of patients with metastatic breast cancer (MBCa) following liver directed ablative intent radiotherapy (RT). Methods: Demographics, disease and treatment characteristics of patients with...
5.
Mushonga M, Abdihamid O, Ntizimira C, Murenzi G, Ka S, Hammad N, et al.
Ecancermedicalscience
. 2023 Apr;
17:1517.
PMID: 37113728
The Choosing Wisely campaign was formally launched in 2012 and a decade later, the inaugural Choosing Wisely Africa conference was held in Dakar, Senegal on 16 December 2022 supported by...
6.
Rubagumya F, Carson L, Mushonga M, Manirakiza A, Murenzi G, Abdihamid O, et al.
BMJ Glob Health
. 2023 Feb;
8(2).
PMID: 36792229
Disparities in cancer research persist around the world. This is especially true in global health research, where high-income countries (HICs) continue to set global health priorities further creating several imbalances...
7.
Mushonga M, Zhu H, Gospodarowicz M, Lopes G
JCO Glob Oncol
. 2023 Feb;
9:e2200414.
PMID: 36780592
No abstract available.
8.
Rubagumya F, Mutebi M, Manirakiza A, Abdihamid O, Mushonga M, Vanderpuye V, et al.
Lancet Oncol
. 2023 Feb;
24(2):e96-e101.
PMID: 36725154
Health-care systems in sub-Saharan Africa are considered to be new markets for pharmaceutical companies. This perception is particularly relevant within oncology, as the pharmaceutical industry has changed strategic priorities in...
9.
Mushonga M, Weiss J, Liu Z, Nyakabau A, Mohamad O, Tawk B, et al.
JCO Glob Oncol
. 2023 Jan;
9:e2200127.
PMID: 36706350
Purpose: Hypofractionated breast radiotherapy has been found to be equivalent to conventional fractionation in many clinical trials. Using data from the European Society for Radiotherapy and Oncology Global Impact of...
10.
Chipidza F, Mushonga M, Kanda C, Chibonda S, Iyer H, Dykstra M, et al.
Breast Cancer Res Treat
. 2021 Aug;
189(3):701-709.
PMID: 34387794
Purpose: Few sub-Saharan African studies have ascertained utilization for postmastectomy radiation (PMRT) for breast cancer, the second most common cancer among African women. We estimated PMRT utilization and identified predictors...